China · Delayed Price · Currency is CNY Sinotherapeutics Statistics
Total Valuation
SHA:688247 has a market cap or net worth of CNY 4.11 billion. The enterprise value is 3.35 billion.
| Market Cap | 4.11B |
| Enterprise Value | 3.35B |
Important Dates
The next confirmed earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688247 has 449.00 million shares outstanding. The number of shares has decreased by -5.35% in one year.
| Current Share Class | 449.00M |
| Shares Outstanding | 449.00M |
| Shares Change (YoY) | -5.35% |
| Shares Change (QoQ) | -18.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.52% |
| Float | 102.52M |
Valuation Ratios
The trailing PE ratio is 83.27.
| PE Ratio | 83.27 |
| Forward PE | n/a |
| PS Ratio | 9.21 |
| PB Ratio | 3.18 |
| P/TBV Ratio | 3.26 |
| P/FCF Ratio | 76.49 |
| P/OCF Ratio | 43.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.83, with an EV/FCF ratio of 62.26.
| EV / Earnings | 70.50 |
| EV / Sales | 7.50 |
| EV / EBITDA | 35.83 |
| EV / EBIT | 54.41 |
| EV / FCF | 62.26 |
Financial Position
The company has a current ratio of 11.27, with a Debt / Equity ratio of 0.00.
| Current Ratio | 11.27 |
| Quick Ratio | 10.08 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.70% and return on invested capital (ROIC) is 10.07%.
| Return on Equity (ROE) | 3.70% |
| Return on Assets (ROA) | 2.66% |
| Return on Invested Capital (ROIC) | 10.07% |
| Return on Capital Employed (ROCE) | 4.54% |
| Weighted Average Cost of Capital (WACC) | 5.37% |
| Revenue Per Employee | 1.43M |
| Profits Per Employee | 152,189 |
| Employee Count | 312 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 3.09 |
Taxes
In the past 12 months, SHA:688247 has paid 5.85 million in taxes.
| Income Tax | 5.85M |
| Effective Tax Rate | 10.97% |
Stock Price Statistics
The stock price has decreased by -6.53% in the last 52 weeks. The beta is 0.20, so SHA:688247's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -6.53% |
| 50-Day Moving Average | 9.61 |
| 200-Day Moving Average | 10.58 |
| Relative Strength Index (RSI) | 46.34 |
| Average Volume (20 Days) | 2,305,108 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688247 had revenue of CNY 446.57 million and earned 47.48 million in profits. Earnings per share was 0.11.
| Revenue | 446.57M |
| Gross Profit | 176.03M |
| Operating Income | 61.52M |
| Pretax Income | 53.34M |
| Net Income | 47.48M |
| EBITDA | 93.35M |
| EBIT | 61.52M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 746.45 million in cash and 22,550 in debt, with a net cash position of 746.43 million or 1.66 per share.
| Cash & Cash Equivalents | 746.45M |
| Total Debt | 22,550 |
| Net Cash | 746.43M |
| Net Cash Per Share | 1.66 |
| Equity (Book Value) | 1.29B |
| Book Value Per Share | 3.52 |
| Working Capital | 851.91M |
Cash Flow
In the last 12 months, operating cash flow was 95.33 million and capital expenditures -41.56 million, giving a free cash flow of 53.77 million.
| Operating Cash Flow | 95.33M |
| Capital Expenditures | -41.56M |
| Depreciation & Amortization | 31.83M |
| Net Borrowing | n/a |
| Free Cash Flow | 53.77M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 39.42%, with operating and profit margins of 13.78% and 10.63%.
| Gross Margin | 39.42% |
| Operating Margin | 13.78% |
| Pretax Margin | 11.94% |
| Profit Margin | 10.63% |
| EBITDA Margin | 20.90% |
| EBIT Margin | 13.78% |
| FCF Margin | 12.04% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | -6.06% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 58.63% |
| Buyback Yield | 5.35% |
| Shareholder Yield | 5.90% |
| Earnings Yield | 1.15% |
| FCF Yield | 1.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |